Drug Topics

MAY 5, 2025

Casey Koch, PharmD, MBA, BCACP, clinical pharmacy coordinator at SelectHealth discusses how pharmacists can reduce patient burden.

415

415

PharmaVoice

MAY 5, 2025

The two obesity leaders are pulling on all levers to stay on top of the market.

Compounding 165

Compounding 165

PhRMA

MAY 5, 2025

PBM’s trade association, PCMA, recently launched a campaign to mask growing concerns over their role in the pharmaceutical supply chain and the rising cost of medicine for patients. The campaign is in response to elected officials nationwide joining the congressional momentum in calling for PBM reform. It’s time to rein in middlemen, like PBMs, who use medicines as a profit center and drive up the costs for patients, employers, and taxpayers.

157

157

STAT

MAY 5, 2025

MILAN — For more than three decades, a charity here has funded research aimed at developing medicines for genetic diseases. Recently, though, it added an unusual new role — as a gene therapy company of sorts.  The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved in Europe to treat an ultra-rare immune disorder called ADA-SCID.

Immunization 136

Immunization 136

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

MAY 5, 2025

While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.

100

100

STAT

MAY 5, 2025

WASHINGTON — Hospitals, health centers, and patient advocates this week plan to escalate their pressure on federal lawmakers to oppose cuts to the Medicaid program. The groups are increasing their public calls to lawmakers, standing up new collaborations, and increasing investments in advertising to discourage lawmakers from cutting hundreds of billions of dollars in the program.

Hospitals 119

Hospitals Insurance 119

STAT

MAY 5, 2025

Having grown up in rural Arkansas, I have an acute awareness of the challenges many in our country face when it comes to health care. Quality care wasn’t always accessible, and the decision of whether to pay medical or utility bills was a real dilemma for my family and others in our community. That is why bringing transformational medicines to patients and advocating for policies that ensure these medicines are rapidly and widely available are so important to me and my 30,000 colleagues.

102

102

European Pharmaceutical Review

MAY 5, 2025

Drug delivery technology is undergoing rapid innovation worldwide. Pharmaceutical manufacturers are adopting advanced delivery platforms to improve drug efficacy and patient compliance, while scaling production for global distribution. In fact, industry analysis shows drug delivery innovation is at an all-time high globally. From nanotechnology-based carriers to smart inhalation devices, these developments are reshaping how therapies are manufactured and administered.

89

89

STAT

MAY 5, 2025

It’s no secret that the new administration has upset normal operations at the Food and Drug Administration: Thousands of employees have been terminated , more than three dozen senior officials are gone , day-to-day operations ranging from communicating product recalls to the public to inspections of food and drug facilities have been upended , and approvals of new products and technologies have been delayed and shelved.

Communication 98

Communication FDA 98

European Pharmaceutical Review

MAY 5, 2025

New clinical findings show that Johnson & Johnsons monoclonal antibody Tremfya (guselkumab) enabled sustained clinical and endoscopic efficacy for ulcerative colitis patients at two years. This is based on the long-term extension study of the Phase III QUASAR trial , which evaluated adults with moderately-to-severely active forms of the disease.

FDA 64

FDA 64

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 5, 2025

Here are a few things we know about how Robert F. Kennedy eats. He likes raw milk , full-fat dairy, and intermittent fasting. He’s suspicious of artificial food dyes and seed oils, and says “ sugar is poison.” He doesn’t drink alcohol. If he spots roadkill, he may try to eat it , though not right away. The health secretary’s personal nutrition views and habits matter because they have direct bearing on the policies of his Make America Healthy Again movement, wh

73

73

pharmaphorum

MAY 5, 2025

FDA decision on oral Wegovy coming in Q4 Jonah.

FDA 59

FDA 59

STAT

MAY 5, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Today, we explore how an ambitious nonprofit is taking control of a shelved gene therapy, as it seeks to create a new model for commercializing treatments no longer deemed lucrative by pharma. Also, we see global scientific worry over internal NIH emails that say international collaborations may be cut off.

FDA 73

FDA 73

PharmExec

MAY 5, 2025

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies, including antibody-drug conjugates.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

MAY 5, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Hi, Morning Rounds editor Karen Pennar, back again. First off, an update to Friday’s newsletter item on NIH’s freeze of subawards to foreign scientists: Megan Molteni has learned that privately, NIH leadership is making it clear that the moves are part of a broader America First agenda that seeks to dramatically reduce U.S. participation in international s

58

58

Pharmaceutical Technology

MAY 5, 2025

China NMPA's Center for Drug Evaluation (CDE) has granted priority review for InnoCare Pharma's zurletrectinib (ICP-723)

52

52

PharmExec

MAY 5, 2025

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

MAY 5, 2025

TAE Life Sciences (TLS) has signed a letter of intent with the OSUCCC James to develop boron-based drug compounds for cancer therapy.

Compounding 52

Compounding 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

MAY 5, 2025

Phenobarbital belongs to a drug class called barbiturates , which are primarily used as seizure medications. Barbiturates are sedative-hypnotic medications, meaning they help you feel sleepy and relaxed. Phenobarbital is FDA approved to prevent and treat several types of seizure disorders, including epilepsy and status epilepticus. The anti-epileptic is also used in addiction treatment for the management of withdrawal symptoms associated with benzodiazepine and alcohol dependence.

Dosage 52

Dosage Controlled Substances Communication Hospitals 52

Drug Topics

MAY 5, 2025

Sarah Thomas and David Skomo of HealthDyne discuss some of the most useful innovations that have been helpful for pharmacies.

Patient Care 315

Patient Care 315

Pharmacy Times

MAY 5, 2025

This installment of our series on ADCs and HER2 breast cancer offers key insights about novel agents in clinical trials and management of ADC therapies.

116

116

STAT

MAY 5, 2025

Charles Lieber, the former chair of Harvard’s chemistry department and renowned nanoscientist who was  convicted of lying to federal agents about his ties to China , was recently announced as a new professor at a Chinese university. Lieber joined the full-time faculty at Tsinghua Shenzhen International Graduate School on April 28 and was appointed to Tsinghua University‘s highest faculty position, the university  announced  this month.

115

115

Pharmacy Times

MAY 5, 2025

As evidence grows for psilocybin-assisted therapys effectiveness in treating mental health and addiction, efforts are increasingly focused on ensuring equitable accessparticularly for underserved communities disproportionately affected by systemic barriers and public health crises.

102

102

Fierce Healthcare

MAY 5, 2025

Virtual MSK provider IncludeHealth rebrands as LainaHealth as the business enters a new chapter, building out its capabilities in computer vision and AI.

98

98

Pharmacy Times

MAY 5, 2025

An insider expressed skepticism about the companys future, indicating that Rite Aid may be looking to close up shop entirely.

94

94

Fierce Healthcare

MAY 5, 2025

Function Health, a preventive health and longevity startup, acquired Ezra to integrate Functions lab testing capabilities with the companys artificial intelligence-powered full-body scans, combining two emerging health trends into one company.

96

96

Pharmacy Times

MAY 5, 2025

Currently, the treatment is undergoing evaluation in a 3-part clinical trial to determine its safety, efficacy, and pharmacokinetics in patients with recurrent advanced/metastatic cancers.

FDA 73

FDA 73

OctariusRx

MAY 5, 2025

Happy National Nurses Week to all our nursing colleagues, clients, friends, and family. National Nurses Week is from May 6 th through May 12th, Florence Nightingales birthday. As usual, the OctariusRx team is taking time to recognize and celebrate all the contributions and sacrifices nurses make daily. Cheers to all nurses! Thank you for dedicating your life to helping others.

73

73

Pharmacy Times

MAY 5, 2025

Cardinal Health is investing in cold chain logistics and packaging solutions to expedite the delivery of novel therapies from FDA approval to patient access.

Packaging 73

Packaging FDA 73

STAT

MAY 5, 2025

Vertex Pharmaceuticals on Monday reported disappointing first-quarter earnings impacted by weaker-than-expected sales of its drugs for cystic fibrosis, and little or no contributions from a gene therapy for sickle cell disease and a recently launched pain medicine.  A “tolerability issue” caused a temporary pause to an early stage study involving a closely watched, inhaled, mRNA-based therapy for cystic fibrosis, the company said.

60

60

Pharmacy Times

MAY 5, 2025

A recent study reveals a significant number of patients with psychiatric histories experience emergency visits after starting glucagon-like peptide-1 (GLP-1) medications, raising safety concerns.

65

65

Fierce Healthcare

MAY 5, 2025

Since the pandemic, leading health systems have re-organized their leadership and organizational structures to streamline telehealth programs. OSF Healthcare, UPMC and WVU Medicine share their experiences.

58

58

Pharmacy Times

MAY 5, 2025

Diana Violanti, PharmD, and Pamela S. Moore, PharmD, BCGP, discuss the nuanced use of anticholinergic agents for managing terminal secretions at end of life, highlighting practical considerations, timing, safety concerns such as delirium, and the limited yet evolving evidence supporting their role in palliative care.

65

65